Company Data
Kazia Therapeutics Limited
Ticker
KZIA
Current Price
$3.56 -4.81%
Market Cap
$4.8M
Price Target
Refer to Report
Volume
7.9K
52wk Range
$2.86 - $395
Overview
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others.